These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33450746)

  • 1. Statin use and outcome risks according to predicted CVD risk in Korea: A retrospective cohort study.
    Jung HH
    PLoS One; 2021; 16(1):e0245609. PubMed ID: 33450746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
    Ramos R; Comas-Cufí M; Martí-Lluch R; Balló E; Ponjoan A; Alves-Cabratosa L; Blanch J; Marrugat J; Elosua R; Grau M; Elosua-Bayes M; García-Ortiz L; Garcia-Gil M
    BMJ; 2018 Sep; 362():k3359. PubMed ID: 30185425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in preventing new-onset cardiovascular events with statin therapy in seniors aged 75 years and over: A cohort study in the South Korean National Health Insurance Database.
    Kim K; Kwak A; Choi CU; Kim JH; Kim MG; Oh JM; Ji E
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):108-116. PubMed ID: 30924261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Statin Therapy on the Risk of Intracerebral Hemorrhage in Korean Patients with Hyperlipidemia.
    Jung M; Lee S
    Pharmacotherapy; 2019 Feb; 39(2):129-139. PubMed ID: 30585646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index.
    Ramos R; García-Gil M; Comas-Cufí M; Quesada M; Marrugat J; Elosua R; Sala J; Grau M; Martí R; Ponjoan A; Alves-Cabratosa L; Blanch J; Bolíbar B
    J Am Coll Cardiol; 2016 Feb; 67(6):630-640. PubMed ID: 26868687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between CVDs and initiation and adherence to statin treatment in patients with newly diagnosed hypercholesterolaemia: a retrospective cohort study.
    Ryou IS; Chang J; Son JS; Ko A; Choi S; Kim K; Kim SM; Park SM
    BMJ Open; 2021 Apr; 11(4):e045375. PubMed ID: 33827840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity of statin therapy and primary prevention of cardiovascular in Korean patients with dyslipidemia.
    Song SO; Kang MJ; Suh S
    Medicine (Baltimore); 2024 Mar; 103(11):e37536. PubMed ID: 38489707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediation effect of herpes zoster derived by statin use on cardiovascular disease risk.
    Kim SH; Yun SC; Khang YH; Kim MC; Kwon SU; Park GM; Cho YR; Lee KM; Kim MH
    Korean J Intern Med; 2020 Sep; 35(5):1220-1228. PubMed ID: 32550721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study.
    Jun JE; Cho IJ; Han K; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Atherosclerosis; 2019 Apr; 283():28-34. PubMed ID: 30772771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults : Real-World Evidence From a Target Trial Emulation Study.
    Xu W; Lee AL; Lam CLK; Danaei G; Wan EYF
    Ann Intern Med; 2024 Jun; 177(6):701-710. PubMed ID: 38801776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of statin use with cataracts: a propensity score-matched analysis.
    Leuschen J; Mortensen EM; Frei CR; Mansi EA; Panday V; Mansi I
    JAMA Ophthalmol; 2013 Nov; 131(11):1427-34. PubMed ID: 24052188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-related adverse drug reactions in UK primary care consultations: A retrospective cohort study to evaluate the risk of cardiovascular events and all-cause mortality.
    Insani WN; Whittlesea C; Ju C; Man KKC; Alwafi H; Alsharif A; Chapman S; Wei L
    Br J Clin Pharmacol; 2022 Nov; 88(11):4902-4914. PubMed ID: 35695656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
    JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Statins as Primary Prevention in People With Gout: A Population-Based Cohort Study.
    Garcia-Gil M; Comas-Cufí M; Ramos R; Martí R; Alves-Cabratosa L; Parramon D; Prieto-Alhambra D; Baena-Díez JM; Salvador-González B; Elosua R; Dégano IR; Marrugat J; Grau M
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):542-550. PubMed ID: 31248268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
    ; Bibbins-Domingo K; Grossman DC; Curry SJ; Davidson KW; Epling JW; García FAR; Gillman MW; Kemper AR; Krist AH; Kurth AE; Landefeld CS; LeFevre ML; Mangione CM; Phillips WR; Owens DK; Phipps MG; Pignone MP
    JAMA; 2016 Nov; 316(19):1997-2007. PubMed ID: 27838723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011.
    Ou HT; Chang KC; Li CY; Yang CY; Ko NY
    Int J Cardiol; 2017 Mar; 230():592-598. PubMed ID: 28062146
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.